Navigation Links
Drugs in the pipeline: new therapies that could change treatment strategies
Date:4/15/2008

SAN DIEGO New drug compounds, and old ones put to new use, offer doctors and patients new hope for treating and preventing cancer. Studies presented at the 2008 Annual Meeting of the American Association for Cancer Research, April 12-16, show promise and progress against brain, colorectal, rectal and ovarian cancers and lymphoma.

A Multidisciplinary Phase II Study of AZD2171 (cediranib), an Oral Pan-VEGF Receptor Tyrosine Kinase Inhibitor, in Patients with Recurrent Glioblastoma: Abstract LB-247

The investigational drug AZD2171 (cediranib) may help shrink tumors and prolong survival of patients with a relatively common, aggressive type of brain cancer, according to results from a clinical trial conducted by Boston researchers.

In a phase II study of 31 patients with recurrent glioblastoma, researchers observed that daily treatment with cediranib decreased tumor volume by more than half in 56 percent of patients.

Nearly 26 percent of patients were alive and their cancer had not progressed six months into treatment. On average, patients experienced a progression-free survival of 117 days and overall survival of 221 days. In addition, cediranib was found to alleviate brain swelling a major cause of morbidity among these patients.

Cediranib is a selective signaling inhibitor for vascular endothelial growth factor (VEGF), which promotes formation of new blood vessels that tumors need for nourishment and growth. The drug targets all three receptors for VEGF, one of which is expressed on the endothelial cells in glioblastoma.

These are promising, early results but are from a single study of 31 patients, so ongoing larger studies will be critical to determine if the findings are corroborated, said lead author Tracy Batchelor, M.D., M.P.H., executive director of the Stephen E. and Catherine Pappas Center for Neuro-Oncology at the Massachusetts General Hospital Cancer Center. One important
'/>"/>

Contact: Staci Vernick Goldberg
Staci.goldberg@aacr.org
267-646-0616
American Association for Cancer Research
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. New review suggests caution on drugs to raise good cholesterol
2. Can cancer drugs combine forces?
3. Study provides hope that some transplant patients could live free of antirejection drugs
4. Study provides hope that some transplant patients could live free of anti-rejection drugs
5. RA Drugs Linked to Slight Skin Cancer Risk
6. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
7. Rock N Roll: Sex, Drugs and an Early Exit
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
10. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
11. 2 drugs equally effective for heart patients undergoing angioplasty, Mayo study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 23, 2013 The Yoga of Lady Niguma ... a thousand years ago. This is the oldest yoga found ... , Lady Niguma was the partner of renowned Indian master and ... series specifically designed by a female yoga master. , Lady ... turn passed it on through a long lineage to the second ...
(Date:5/22/2013)... 2013 A new study published online today ... of young people who visited fast food or chain restaurants ... obese were more likely to use calorie information given in ... that young people eating at fast food or chain restaurants ... use calorie information as those eating there once a week ...
(Date:5/22/2013)... Hosted by the California Dental Association Foundation ... more than $1.6 million in charitable dental services during ... , The California Dental Association Foundation and the ... dental services and oral health education to Californians who ... held by CDA and CDAF in the past 12 ...
(Date:5/22/2013)... 2013 Zensah® Compression Apparel released a ... titled "Breast pain while running affects one-third ... could help." According to the article, a British study ... amount suffer from breast pain while running but do ... issue. , Zensah emphasizes the importance for women ...
(Date:5/22/2013)... Dennis Thompson HealthDay Reporter , , WEDNESDAY, May ... or back pain are more likely to attempt suicide, ... another psychiatric condition, according to a new study. ... should be aware they are at increased risk of ... Affairs Serious Mental Illness Treatment Resource and Evaluation Center ...
Breaking Medicine News(10 mins):Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 2Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 3Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 2Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 3Health News:Two-day San Jose Dental Clinic Provides More Than $1.6 Million in Care 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 3Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 3
... failing to meet national goals in treating many heart ... Johns Hopkins researchers published in the October issue of ... that also found care levels dependent on race, geography ... of 1,492 heart attack patients and 3,955 pneumonia patients ...
... -- High-blood-pressure patients treated for enlarged heart (left ... of LVH may also have a better chance ... Hospital/Weill Cornell Medical Center, the research is published ... American Heart Association (AHA). , An estimated 20 ...
... TSX, MONTREAL, Oct. 31 /PRNewswire-FirstCall/ - Haemacure ... of,its presentation at the Acumen BioFin Rodman & ... at 11:30 a.m. at the New York,Palace Hotel ... webcast the audio portion of the presentation and,post ...
... Response Genetics, Inc.,(Nasdaq: RGDX ) today announced ... overview, including an update on its ERCC-1,molecular diagnostic gene ... Conference at the San Diego Marriot Del,Mar in San ... present at,5:30 p.m. PT Thursday, Nov. 1. The ...
... Study finds 10% improvement with cholesterol drugs , , WEDNESDAY, ... statins to lower their cholesterol had a 10 percent ... radiation therapy 10 years after diagnosis, a new study ... but falls short of supporting statin use for all ...
... Plan in Pennsylvania, PITTSBURGH, Oct. 31 U.S. ... Assurance (NCQA) recently released its third,report on health plans, ... Gateway Health Plan is ranked #12 among 196 Medicaid,plans ... "Gateway Health Plan is extremely proud to once ...
Cached Medicine News:Health News:Heart attacks/pneumonia falls short of national goals 2Health News:Preventing or reducing enlarged heart may decrease risk for diabetes 2Health News:Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec 2Health News:Response Genetics Announces Presentation/Webcast at BIOCOM Investor Conference 2Health News:Better Prostate Cancer Survival for Men Taking Statins 2Health News:Gateway Health Plan Ranked Again Among 'America's Best Health Plans' According to U.S. News & World Report, NCQA 2
(Date:5/22/2013)... OREM, Utah , May 22, 2013  Aribex, ... handheld X-ray system, today introduced a new color option, ... into the U.S. dental and veterinary markets. The popular ... released last month will continue to be available and ... equipment dealers. (Photo: http://photos.prnewswire.com/prnh/20130522/CL19573 ) ...
(Date:5/22/2013)... Conn. , May 22, 2013 /PRNewswire-iReach/ -- ... stay aligned with the latest trends and events, ... that can predict where an industry is headed ... evolve. (Photo: http://photos.prnewswire.com/prnh/20130522/CG19099 ) ... partnership with market research publisher GlobalData, offer decision ...
(Date:5/22/2013)... 22, 2013  The Leukemia & Lymphoma Society (LLS) ... Biotherapeutics, LLC, a joint venture between ImmunGene and Caliber, ... a Phase I clinical trial for a novel fusion ... many patients with indolent lymphomas who do not respond ... protein, IGN002, is a new class of biotherapeutics produced ...
Breaking Medicine Technology:Aribex Unveils New Color of NOMAD Pro 2 2Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 2Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 3Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 4The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4
... 2011 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... Executive Officer of Neurocrine Biosciences, will be presenting at ... New York.    The live presentation takes place ... Time / 8:00 a.m. Pacific Time.  The presentation will ...
... Nov. 23, 2011 Dune Medical Devices, Inc. today ... the 23rd Annual Piper Jaffray Healthcare Conference and will ... PM on Wednesday, November 30, 2011. The ... & 30, 2011 at the New York Palace Hotel, ...
Cached Medicine Technology:
Angled Castroviejo handle. Manufactured in titanium. Overall length 4.2 inches....
Curved shafts and tips with 6.5 mm tying platform. Flat serrated handle with dull finish. Overall length 4.0 inches....
Angled 45 degree shafts 10 mm tying platform. Serrated handle with dull finish. Overall length 3.3 inches....
Ultra-fine 5 mm tying platform is valuable when manipulating delicate 10-0 and 11-0 sutures. Pin in handle keeps tips in alignment. Shafts available straight or angled 45 degrees, 8 mm from tip. Angl...
Medicine Products: